Is IgE or eosinophils the key player in allergic asthma pathogenesis? Are we asking the right question?
Abstract Bronchial asthma (BA) is a chronic inflammatory disease with a marked heterogeneity in pathophysiology and etiology. The heterogeneity of BA may be related to the inducing mechanism(s) (allergic vs non-allergic), the histopathological background (eosinophilic vs non-eosinophilic), and the c...
Main Authors: | Andrea Matucci, Alessandra Vultaggio, Enrico Maggi, Ismail Kasujee |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-06-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-018-0813-0 |
Similar Items
-
Anti-IgE therapy for IgE-mediated allergic diseases: from neutralizing IgE antibodies to eliminating IgE+ B cells
by: Jiayun Hu, et al.
Published: (2018-07-01) -
Allergic children with extremely high total IgE but no allergen identified in the initial screening panel
by: I-Hui Lin, et al.
Published: (2021-06-01) -
Assessment of serum IgE levels in patients of allergic rhinitis
by: Mallikarjun S. Tegnoor, et al.
Published: (2017-04-01) -
Regulation of IgE activity in inhalational tolerance via formation of IgG anti-IgE/IgE immune complexes
by: Sonali J. Bracken, et al.
Published: (2018-05-01) -
B Cell Intrinsic Mechanisms Constraining IgE Memory
by: Brice Laffleur, et al.
Published: (2017-11-01)